Depression is accompanied by neuronal atrophy and decreased neuroplasticity. Leucine-rich glioma-inactivated protein 1 (LGI1), a metastasis suppressor, plays an important role in the development of CNS synapses. We found that LGI1 expression was reduced in the hippocampi of mice that underwent chronic unpredictable stress (CUS), and could be rescued by the antidepressant, fluoxetine. Recombinant soluble neuritin, an endogenous protein previously implicated in antidepressant-like behaviors, elevated hippocampal LGI1 expression in a manner dependent on histone deacetylase 5 (HDAC5) phosphorylation. Accordingly, ( cOE) mice, which conditionally overexpress neuritin, displayed increases in hippocampal LGI1 level under CUS and exhibited resilience to CUS that were blocked by hippocampal depletion of LGI1. Interestingly, neuritin-mediated LGI1 expression was inhibited by HNMPA-(AM), an insulin receptor inhibitor, as was neuritin-mediated HDAC5 phosphorylation. We thus establish hippocampal LGI1 as an effector of neurite outgrowth and stress resilience, and suggest that HDAC5-LGI1 plays a critical role in ameliorating pathological depression.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350063 | PMC |
| http://dx.doi.org/10.1016/j.ynstr.2021.100373 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A role for leucine-rich, glioma inactivated 1 in regulating pain sensitivity.
Brain
September 2024
Nuffield Department of Clinical Neurosciences, University of Oxford, OX3 9DU, UK.
Neuronal hyperexcitability is a key driver of persistent pain states including neuropathic pain. Leucine-rich, glioma inactivated 1 (LGI1), is a secreted protein known to regulate excitability within the nervous system and is the target of autoantibodies from neuropathic pain patients. Therapies that block or reduce antibody levels are effective at relieving pain in these patients, suggesting that LGI1 has an important role in clinical pain.
View Article and Find Full Text PDFB cell and aquaporin-4 antibody relationships with neuromyelitis optica spectrum disorder activity.
Ann Clin Transl Neurol
October 2024
UCSF Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, California, USA.
This post hoc analysis of the randomized, placebo-controlled N-MOmentum study (NCT02200770) of inebilizumab in neuromyelitis optica spectrum disorder (NMOSD) evaluated relationships between circulating B-cell subsets and aquaporin-4 immunoglobulin G (AQP4-lgG) titers and attacks. Among participants receiving placebo, CD20 and CD27 B-cell counts were modestly increased from the pre-attack visit to attack; plasmablast/plasma cell gene signature was increased from baseline to the pre-attack visit (p = 0.016) and from baseline to attack (p = 0.
View Article and Find Full Text PDFRETRACTION: Increased expression of LGI1 gene triggers growth inhibition and apoptosis of neuroblastoma cells.
J Cell Physiol
November 2024
N. Gabellini, V. Masola, S.
View Article and Find Full Text PDFOPALIN is an LGI1 receptor promoting oligodendrocyte differentiation.
Proc Natl Acad Sci U S A
August 2024
Guangdong Institute of Intelligence Science and Technology, 519031 Hengqin, Zhuhai, China.
Article Synopsis
- - The study investigates the role of LGI1, a brain protein, in myelination, and finds that its dysfunction leads to hypomyelination and white matter issues.
- - Researchers identified OPALIN, a membrane protein on oligodendrocytes, as the receptor that binds to LGI1, and its absence in mouse models resulted in similar myelination problems as seen with LGI1 deficiency.
- - Restoring OPALIN in genetically modified mice reversed the myelination issues, confirming the critical role of the LGI1/OPALIN interaction in oligodendrocyte development and function.
HLA and KIR genetic association and NK cells in anti-NMDAR encephalitis.
Front Immunol
July 2024
Stanford Center for Sleep Science and Medicine, Stanford University, Palo Alto, CA, United States.
Introduction: Genetic predisposition to autoimmune encephalitis with antibodies against N-methyl-D-aspartate receptor (NMDAR) is poorly understood. Given the diversity of associated environmental factors (tumors, infections), we hypothesized that human leukocyte antigen () and killer-cell immunoglobulin-like receptors (), two extremely polymorphic gene complexes key to the immune system, might be relevant for the genetic predisposition to anti-NMDAR encephalitis. Notably, KIR are chiefly expressed by Natural Killer (NK) cells, recognize distinct HLA class I allotypes and play a major role in anti-tumor and anti-infection responses.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!